IShares Genomics Etf Forecast - Day Median Price
| IDNA Etf | USD 23.86 0.51 2.18% |
IShares Etf Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast IShares Genomics stock prices and determine the direction of iShares Genomics Immunology's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of IShares Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of IShares Genomics to cross-verify your projections. IShares |
Open Interest Against 2024-05-17 IShares Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast IShares Genomics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in IShares Genomics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for IShares Genomics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current IShares Genomics' open interest, investors have to compare it to IShares Genomics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of IShares Genomics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in IShares. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in IShares Genomics cannot accurately predict what will happen the next trading day because, historically, etf markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the IShares Genomics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets IShares Genomics' price structures and extracts relationships that further increase the generated results' accuracy.
Median Price is the statistical median of an asset price for a given trading period.| Previous Day Median Price | Day Median Price | Trend |
| 23.82 | 23.82 |
| Check IShares Genomics Volatility | Backtest IShares Genomics | Information Ratio |
IShares Genomics Trading Date Momentum
| On May 05 2024 iShares Genomics Immunology was traded for 23.86 at the closing time. The top price for the day was 23.99 and the lowest listed price was 23.64 . There was no trading activity during the period 0.0. Lack of trading volume on May 5, 2024 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 0.67% . |
The median price is the midpoint of the trading periods range.
| Compare IShares Genomics to competition |
Other Forecasting Options for IShares Genomics
For every potential investor in IShares, whether a beginner or expert, IShares Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. IShares Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in IShares. Basic forecasting techniques help filter out the noise by identifying IShares Genomics' price trends.IShares Genomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IShares Genomics etf to make a market-neutral strategy. Peer analysis of IShares Genomics could also be used in its relative valuation, which is a method of valuing IShares Genomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
iShares Genomics Imm Technical and Predictive Analytics
The etf market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of IShares Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of IShares Genomics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
IShares Genomics Market Strength Events
Market strength indicators help investors to evaluate how IShares Genomics etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IShares Genomics shares will generate the highest return on investment. By undertsting and applying IShares Genomics etf market strength indicators, traders can identify iShares Genomics Immunology entry and exit signals to maximize returns.
IShares Genomics Risk Indicators
The analysis of IShares Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in IShares Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ishares etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.14 | |||
| Semi Deviation | 1.29 | |||
| Standard Deviation | 1.4 | |||
| Variance | 1.95 | |||
| Downside Variance | 1.96 | |||
| Semi Variance | 1.66 | |||
| Expected Short fall | (1.22) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of IShares Genomics to cross-verify your projections. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.